Navigation Links
The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide
Date:6/8/2009

NEW ORLEANS, June 8 /PRNewswire/ -- Today, The Lancet published online the results of the Novo Nordisk (NVO) LEAD(TM) 6 study, a direct comparison between two products in a new class of diabetes treatments, the GLP-1 receptor agonists. Results show that patients treated with liraglutide had a statistically greater drop in A1C than those who received exenatide.

The study compared liraglutide, a human GLP-1 analog, which is under investigation as a treatment for type 2 diabetes, to exenatide, the currently marketed GLP-1 receptor agonist.

"Because of the differences in how the body absorbs and eliminates these two compounds, we were very interested to see if there were clinically meaningful differences in the effect in people with diabetes," said Dr. John Buse, chief of endocrinology and director of the Diabetes Care Center at the University of North Carolina School of Medicine, and one of the principal investigators in the study. "The clinical benefits that liraglutide provides -- from greater glucose lowering to weight loss to better tolerability and improvements in beta-cell function -- represent a clinically meaningful treatment advance for patients with type 2 diabetes."

LEAD(TM) 6 was a randomized, open-label study comparing the efficacy and safety of liraglutide 1.8 milligrams, once a day, to exenatide 10 micrograms, twice a day.

Treatment with liraglutide led to a statistically significantly greater drop in A1C of 1.12% compared to 0.79% in the exenatide group, and liraglutide was also significantly better than exenatide at lowering fasting plasma glucose (-1.61 mmol/L vs -0.60 mmol/L) in this typical type 2 diabetes population. The study comprised 464 patients who were not reaching recommended blood sugar targets on either the maximally tolerated doses of metformin, sulphonylurea, or both, which are standard oral antidiabetic medications currently availabl
'/>"/>

SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
2. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
3. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
4. Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
5. TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
6. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
7. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
8. Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine
9. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
10. SurgiLance Safety Lancet Part of Major HIV Testing Initiative in Sub-Saharan Africa
11. International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... AARP Foundation today announced it has established a ... severe cold weather that has gripped much of the nation. ... need; so to support these emergency relief efforts AARP and ... could mean up to $500,000 in aid. The matching program ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... an unprecedented effort to curb the spread of "superbugs" such as ... an advanced and portable UV germicidal lamp manufactured by MRSA-UV is ... In order to prevent EMS paramedics and transport patients ... Palm Beach Fire Rescue is the first in the ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2
... BOZEN, Sud-Tirol, Italy , July 20, 2010 ... rights in Spain and Portugal to world-leading IV,Therapy company ... at Vall d,Hebron University Hospital in Barcelona in November,2010 . ... "We are ...
... , WILMINGTON, Del. , July 20 ... Be Heard… Living With Depression contest, ... Bipolar Support Alliance (DBSA), encourages people with depressive symptoms of ... depression) to share their stories of success.  Submissions are now ...
Cached Medicine Technology:Health Robotics' CytoCare Continues European Expansion With Grifols and Vall d'Hebron University Hospital 2Health Robotics' CytoCare Continues European Expansion With Grifols and Vall d'Hebron University Hospital 3Health Robotics' CytoCare Continues European Expansion With Grifols and Vall d'Hebron University Hospital 4National Contest Encourages People with Depressive Symptoms of Bipolar Disorder or Major Depressive Disorder to Speak Out 2National Contest Encourages People with Depressive Symptoms of Bipolar Disorder or Major Depressive Disorder to Speak Out 3National Contest Encourages People with Depressive Symptoms of Bipolar Disorder or Major Depressive Disorder to Speak Out 4National Contest Encourages People with Depressive Symptoms of Bipolar Disorder or Major Depressive Disorder to Speak Out 5National Contest Encourages People with Depressive Symptoms of Bipolar Disorder or Major Depressive Disorder to Speak Out 6National Contest Encourages People with Depressive Symptoms of Bipolar Disorder or Major Depressive Disorder to Speak Out 7
(Date:7/11/2014)... 11, 2014 This is a ... of the Cholesterol industry in Global and China. ... industry, including definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
(Date:7/11/2014)... The International Concussion Organization is hosting its ... Theater in Times Square, New York on July ... epidemic that is plaguing athletes in nearly all ... The Symposium gathers more than a dozen internationally ... and legal scholars for engaging and uniquely relevant ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 This morning(July 9th, ... 13--Good Morning Memphis to discuss the illegal immigration crisis at ... town of McAllen, Texas. , Dr. Flinn told Good Morning ... is absolutely wide open… The problem is that they do ... Thousands of people per day are coming into the border; ...
(Date:7/11/2014)... the hot Texas sun won’t keep kids from having fun ... school had previously invested in a playground structure to augment ... asked for an innovative solution to help protect children from ... a Rectangular Shade from APCPLAY as the perfect solution to ... The shade measures 24’W x 34’H x 11’H to fully ...
(Date:7/11/2014)... ASHBURN PSYCHOLOGICAL AND PSYCHIATRIC SERVICES , On ... with an intellectual disability or autism to have a special ... cards to alert law enforcement or first responders that they ... was inspired by a central Virginia mother, Ms. Pam Mines, ... old autistic son, JP. During a news conference after ...
Breaking Medicine News(10 mins):Health News:Cholesterol Industry 2014 Development Trends in Global & China Regions in a New Research Study Available at DeepResearchReports.com 2Health News:Cholesterol Industry 2014 Development Trends in Global & China Regions in a New Research Study Available at DeepResearchReports.com 3Health News:The International Concussion Organization 501(c)(3) hosts its 1st Annual Concussion Symposium at the Best Buy Theater in Time Square, NYC, July 17th, 2014. 2Health News:Senate Candidate, George Flinn on Fox13 NEWS About the Border Crisis 2Health News:Cool Fun Under the Texas Sun: Godley Elementary School Purchases Shade Structure from APCPLAY© 2Health News:Recent Special “Autism” Code on Virginia Driver’s Licenses and ID Cards Goes into Law: Helpful or Discriminatory for Individuals on the Autistic Spectrum? 2Health News:Recent Special “Autism” Code on Virginia Driver’s Licenses and ID Cards Goes into Law: Helpful or Discriminatory for Individuals on the Autistic Spectrum? 3
... ... the year – the first day of summer – celebrates the many great, natural ... ... illumination of outdoor sunshine due to work, school, or issues that keep people indoors, ...
... Diclofenac plus proton pump inhibitor quadrupled risk of ... (HealthDay News) -- Patients who take the painkiller ... likely to suffer gastrointestinal damage than those who ... , Celecoxib (Celebrex) is a cox-2 selective non-steroidal ...
... Many of our ... scarcity have steep energy costs. , ... (PRWEB) June 17, 2010 -- This June award winning publication, IEEE Spectrum features how ... According to a new special report in IEEE Spectrum magazine, the flagship monthly publication of ...
... ... as an Engineered Sales Representative for Ellsworth Adhesives S. de R.L. de C.V. (Mexico). ... Germantown, WI (PRWEB) June ... an Engineered Sales Representative for Ellsworth Adhesives S. de R.L. de C.V. (Mexico). In ...
... 2010 - There is a great deal of interest in ... disorder, or PTSD. One factor that appears to contribute ... the gene that codes for the serotonin transporter, also known ... of the serotonin transporter gene appears to increase one,s risk ...
... may bolster the metabolic profiles of college students, even ... In an epidemiological study, researchers at the Friedman School ... an association between physical fitness, body fat percentage and ... disease and Type 2 diabetes. The data ...
Cached Medicine News:Health News:Celebrate the First Day of Summer on Daylight Appreciation Day, June 21 2Health News:Celebrate the First Day of Summer on Daylight Appreciation Day, June 21 3Health News:Celebrex Appears Easier on Stomach for Arthritis Patients 2Health News:Green Energy May Drain Our Water Supplies 2Health News:Green Energy May Drain Our Water Supplies 3Health News:Ellsworth Adhesives Announces New International Engineered Sales Representative 2Health News:PTSD: The serotonin system influences vulnerability and treatment 2Health News:Physical fitness may help reduce chronic disease risk in college students 2
... Mosaic, the third generation tissue valve ... stented tissue valve available. The Mosaic valve ... experience and is an excellent choice for ... replacement with a tissue valve. For more ...
... bioprosthesis from Medtronic has more ... clinical experience. Worldwide clinical studies ... structural valve deterioration with Hancock® ... is substantially better than results ...
... The Hancock® II bioprosthesis ... 15 years of proven clinical ... that the freedom from structural ... aortic and mitral bioprostheses is ...
Attain Venogram Balloon Catheter....
Medicine Products: